Table 1.
Descriptive data for the demographic and clinical variables are presented.
| Variable | Experimental group (n = 40) | Control group (n = 40) | P value |
|---|---|---|---|
| Age (years) | 21.5 ± 2.7 | 23.9 ± 3.1 | 0.07 |
| Weight (kg) pre-treatment treatment | 69.2 ± 4.7 | 72.2 ± 5.1 | 0.14 |
| Gender (%) | |||
| Male | 25 (62.5%) | 23 (57.5%) | 0.4 |
| Female | 15 (37.5%) | 17 (42.5%) | |
| Outcome measures | |||
| AHT (mm) | 2.4 ± 0.4 | 2.3 ± 0.3 | 0.5 |
| ARA C2–C7 (°) | 4.16 ± 4.15 | 4.2 ± 4.5 | 0.7 |
| P14 | 0.96 ± 0.21 | 1.045 ± 0.24 | 0.10 |
| N20 | 2.44 ± 0.4 | 2.5 ± 0.38 | 0.4 |
| P27 | 1.9 ± 0.27 | 2.02 ± 0.4 | 0.10 |
| N30 | 1.9 ± 0.2 | 2.1 ± 0.3 | 0.3 |
| N13–N20 | 5.7 ± 0.3 | 5.7 ± 0.3 | 0.31 |
| N13 | 1.2 ± 0.16 | 1.01 ± 0.24 | 0.002 |
No statistically significant differences between the control group and the experimental group were found at baseline for their demographic and clinical variables, except for N13 (P = 0.0022). The values are presented as mean and standard deviation (SD) for age, weight, anterior head translation (AHT), absolute rotation angle (ARA C2–C7 lordosis), and neurophysiological parameters.